24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Dr. Arno Mundt is a board-certified radiation oncologist based in San Diego, California. He graduated from the University of Michigan Medical School and then did his internship at the George Washington University. He pursued Radiation Oncology residency at the University of Chicago and a residency in Physical Medicine and Rehabilitation at the George Washington University. Dr. Mundt has been practicing medicine for more than two decades and treats cancer patients at multiple hospitals including the VA San Diego Healthcare System, UC San Diego Health System, and Tri-City Medical Center. He has also authored several clinical research papers.
University of Michigan Medical School
Medical School
George Washington University
Internship
University of Chicago
Residency
George Washington University
Residency
American Board of Radiology - Radiation Oncology
Tri City Medical Center
Languages: English/Spanish
(760) 724-8411
4002 Vista Way
Oceanside, California 92056 
UC San Diego Health System
Languages: English/Spanish
(858) 657-7000
200 West Arbor Drive
San Diego, California 92103
VA San Diego Healthcare System
Languages: English/Spanish
(858) 552-8585
3350 La Jolla Village Dr
San Diego, California 92161
The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management.
Huq, M. S.,Fraass, B. A.,Dunscombe, P. B.,Gibbons, J. P.,Ibbott, G. S.,Mundt, A. J.,Mutic, S.,Palta, J. R.,Rath, F.,Thomadsen, B. R.,Williamson, J. F.,Yorke, E. D.; Med Phys. 2016 Jul 03.
See more >>
Adverse Events Involving Radiation Oncology Medical Devices: Comprehensive Analysis of US Food and Drug Administration Data, 1991 to 2015.
Connor, M. J.,Marshall, D. C.,Moiseenko, V.,Moore, K.,Cervino, L.,Atwood, T.,Sanghvi, P.,Mundt, A. J.,Pawlicki, T.,Recht, A.,Hattangadi-Gluth, J. A.; Int. J. Radiat. Oncol. Biol. Phys.. 2016 Dec 17.
See more >>
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).
Mell, L. K.,Sirák, I.,Wei, L.,Tarnawski, R.,Mahantshetty, U.,Yashar, C. M.,McHale, M. T.,Xu, R.,Honerkamp-Smith, G.,Carmona, R.,Wright, M.,Williamson, C. W.,Kasaová, L...; Int. J. Radiat. Oncol. Biol. Phys.. 2017 Jan 28.
See more >>
Hospitals & Clinics
specialties & services
